United States Viral Vector and Plasmid DNA Manufacturing Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

1.       Report Overview

1.1.    Report Description

1.2.    Research Methods

1.3.    Research Approaches

2.       Executive Summary

3.       Market Overview

3.1.    Introduction

3.2.    Market Dynamics

3.2.1.Drivers

3.2.2.Restraints

3.2.3.Opportunities

3.2.4.Challenges

3.3.    PEST-Analysis

3.4.    Porter's Diamond Model for the United States Viral Vector and Plasmid DNA Manufacturing Market

3.5.    IGR-Growth Matrix Analysis

3.6.    Competitive Landscape in the United States Viral Vector and Plasmid DNA Manufacturing Market

4.       United States Viral Vector and Plasmid DNA Manufacturing Market by Type

4.1.    Adenovirus

4.2.    Lentivirus

4.3.    Adeno-associated Virus

4.4.    Plasmid DNA

4.5.    Other

5.       United States Viral Vector and Plasmid DNA Manufacturing Market by Application

5.1.    Gene Therapy

5.2.    Vaccinology

5.3.    Other Applications

6.       United States Viral Vector and Plasmid DNA Manufacturing Market by Disease

6.1.    Cancer

6.2.    Genetic Disorders

6.3.    Infectious Disease

6.4.    Other Disease

7.       United States Viral Vector and Plasmid DNA Manufacturing Market by End User

7.1.    Biotech Companies

7.2.    Research Institutes

8.       Company Profiles

8.1.    Company 1

8.2.    Company 2

8.3.    Company 3

8.4.    Company 4

8.5.    Company 5